We are an advisory company that creates strategies for precision medicine and precision health to advance healthy lifespan.
Why Us?
We span the fields of biopharmaceuticals, including gene and cell therapies, molecular diagnostics, digital health and longevity science. We bring in the experience of working with industry leaders, public healthcare systems and governments, which makes us different from technology transfer specialists working at the academia-industry interface. We view technologies from the growth, value proposition and revenue generation perspective.
National and Health
System Strategies for
Healthy Longevity
System Strategies for
Healthy Longevity
Strategic Advisory in
Accelerating Potentially
Disruptive Early-Stage
Technologies to Advance
Healthy Lifespan
Accelerating Potentially
Disruptive Early-Stage
Technologies to Advance
Healthy Lifespan
Technology Selection and
Appraisal
for Investment
for Investment
Example Projects
SweatCoin
NMP is assisting this fast-growing UK-based international company in using its technology to advance exercise-based healthy longevity in a variety of populations.
Veratrak
NMP is assisting this UK-based startup company in using its technology to revolutionise pharmaceutical supply chains including COVID-19 and cell and gene therapies.
The members of the Faculty of Pharmaceutical Medicine, including NMP's advisor on Clinical and Pharmaceutical Medicine, Prof. Andrew J. Krentz M.D., F.R.C.P., F.F.P.M. open the discussion of the principles of #COVID-19 #clinicalstudies. https://www.fpm.org.uk/blog/principles-for-clinical-studies-into-covid-19/
